CPRX - Catalyst Pharmaceuticals, Inc. Operating profit EBITDA
The growing number of Firdapse consumers strengthens the position of Catalyst Pharmaceuticals (CPRX) within the orphan drug niche. The EBITDA level reflects cash flow dynamics, where 307.68 captures the current state of the parameter. The company's potential is based on the creation of a therapy delivery infrastructure for patients with rare diseases and strict adherence to environmental standards in the production of neurological drugs.
Catalyst Pharmaceuticals, Inc. - analytical breakdowns and key metrics (CPRX)
- current price and projected stock value:
- market capitalization statistics:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Catalyst Pharmaceuticals|CPRX - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Catalyst Pharma|CPRX - Company Total Debt|Debt to Net Assets Ratio Catalyst Pharmaceuticals|CPRX - Company Long-Term Debt|Current Liabilities Catalyst Pharmaceuticals|Intermediate Coverage Ratio catalystpharma.com
- net income and valuation multiples indicators:
CPRX - Net Profit|Projected Future Earnings Catalyst Pharmaceuticals|CPRX - Price to Earnings Ratio|Future Price to Earnings Multiple catalystpharma.com|CPRX - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Catalyst Pharmaceuticals|CPRX - Operating profit EBITDA|Net earnings per share (EPS TTM) Catalyst Pharmaceuticals|CPRX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months catalystpharma.com|CPRX - Earnings growth in current year|Expected net earnings per share growth next year Catalyst Pharmaceuticals
Fundamental company valuation:Catalyst Corp
For the investor, the stability of Catalyst Pharmaceuticals (CPRX) cash flow confirms the effectiveness of its monopoly position in the treatment of Lambert-Eaton myasthenic syndrome via the drug Firdapse. An analysis of the absolute EBITDA volume allows for an assessment of the business's net operating efficiency without the influence of taxes and debt load, where the upward trajectory of the chart reflects the company's capitalization of its pricing power and the resilience of its fundamental cash inflows.
Competitors of Catalyst Pharmaceuticals (CPRX)
Company profit before taxes, interest and amortization BIIB (Biogen Idec)|Neurocrine Biosciences - Operating profit EBITDA|RGC - Operating profit EBITDA|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|ACAD (ACADIA Pharma) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization XENE|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Profit before payment of interest, taxes and amortization Supernus Pharmaceuticals (SUPN)|Operating income before deduction of amortization denalitherapeutics.com|Harmony Biosciences Holdings, Inc. - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization BHVN (Biohaven Ltd)|AMLX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization TRVI (Trevi Corp)|Praxis Precision Medicines (PRAX) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization AVXL (anavex.com)|CBLL (CeriBell) - Operating profit EBITDA|PRTA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA ALEC|Operating profit EBITDA Annexon Biosciences Inc. (ANNX)|Profit before payment of interest, taxes and amortization Omeros OMER|Income before deduction of interest, taxes and amortization NGNE|ACIU - Profit before payment of interest, taxes and amortization|Voyager Therapeutics Inc (VYGR) - Operating profit before deduction of amortization|NMRA: Operating profit EBITDA|Scilex Holding Company, Inc. (SCLX) - Operating profit EBITDA|TVGN (Tevogen Bio Holdings) - Operating profit EBITDA|Operating profit before deduction of amortization Alpha Cognition Corp (ACOG)|Operating profit EBITDA CGTX|IKT - Profit before interest, taxes and amortization|Cassava - Operating profit before deduction of amortization|Operating profit EBITDA Assertio Holdings ASRT|COYA: Operating profit before deduction of amortization|Vistagen Therapeutics - Company profit before taxes, interest and amortization|OVID: Operating profit EBITDA|ABOS - Operating income before deduction of amortization|CRVO (CervoMed Inc) - Operating profit EBITDA|Operating profit before deduction of amortization Alterity Therapeutics Ltd (ATHE)|Operating profit EBITDA CLNN|Operating profit EBITDA pepgen.com (PEPG)|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|Relmada Therapeutics Inc - Profit before payment of interest, taxes and amortization|ANVS - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Grace Therapeutics, Inc. GRCE|AIFF: Operating profit EBITDA|Operating profit before deduction of amortization Klotho Neurosciences|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals Holdings Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS (NeurAxis Inc) - Income before deduction of interest, taxes and amortization|Helius Medical Technologies - Operating profit before deduction of amortization|PASG: Operating profit before amortization|NEUP - Profit before payment of interest, taxes and amortization|NERV (Minerva Neurosciences Inc) - Operating profit before amortization|ATHA: Operating profit EBITDA|Profit before interest, taxes and amortization Addex (ADXN)|Operating profit before deduction of amortization ALZN|Operating profit EBITDA Cyclerion|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cortigent CRGT|Avenue Therapeutics Inc (ATXI) - Profit before interest, taxes and amortization|Brainstorm Cell - Operating profit EBITDA|caratherapeutics.com (CARA) - Operating profit before deduction of amortization|CHRO: Operating profit EBITDA|Eliem Therapeutics Inc. (ELYM) - Operating profit EBITDA|Operating profit before deduction of amortization ITCI|LBPH (Longboard) - Company profit before taxes, interest and amortization|Operating profit EBITDA MRNS|Operating profit EBITDA nkgenbiotech.com (NKGN)|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|Sage Therapeutics Inc. - Profit before payment of interest, taxes and amortization|SNPX: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Trevena Inc|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|WENA - Operating income before deduction of amortization|Operating profit before deduction of amortization CERE
